Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2009/2010 Recommended in Northern Hemisphere in Non-elderly Adult and in Elderly Subjects
Clinical trial NCT00918268 · COMPLETED
Trial details
- NCT number
- NCT00918268
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2009-07-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.